Veterinary Medicines

Kolierysin Neo injekčná emulzia

Authorised
  • Escherichia coli (inactivated)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, strain 203, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
Download as PDF

Product identification

Medicine name:
Kolierysin Neo injekčná emulzia
Active substance:
  • Escherichia coli (inactivated)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, strain 203, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli (inactivated)
    54.00
    billion colony forming units
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
    200.00
    billion colony forming units
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
    200.00
    billion colony forming units
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 1, strain 203, Inactivated
    200.00
    billion colony forming units
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
    200.00
    billion colony forming units
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/018/02-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 7/11/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."